Skip to content
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Perrigo Company plc......
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a......
Yahoo Finance’s Brian Cheung joins the On The Move panel to discuss Taco Bell’s $100,000 salary for general managers and the impact it could have on the company....
Dividend paying stocks like Douglas Dynamics, Inc. (NYSE:PLOW) tend to be popular with investors, and for good reason......
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 57% each. Hedge funds' top 3 stock picks returned 45.7% last year and beat the S&P 500 ETFs by […]...
Heading into the new year, only one word matters for the biotech stocks: buyout.Already, we've seen a fury of activity this past year, as many of the larger pharmaceutical and biotech giants look to plug holes in their aging pipelines. This activity accelerated at the end of the end, with Novartis (NYSE:NVS), Merck (NYSE:MRK) and Sanofi (NASDAQ:SNY) all making big blockbuster buys over the last month or so.And, the buys could continue into the new year.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFor one thing, many of the big biotech stocks are flushed with cash. Thanks to the tax cuts of 2017, repatriation of cash and continued sales of blockbuster drugs, many of the biggest biotech stocks are holding billions on their balance sheets. Meanwhile, pipelines and approvals of new drugs are starting to dry up. According to investment bank JPMorgan Chase (NYSE:JPM), over the last 20 years, the...
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios......
